Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Advanced Algorithms for Treatment Management Applications (AATMA)

K-Number: K212218 · 2021-10-25

ApplicantElekta Solutions AB
Decision Date2021-10-25
Product CodeQKB
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Advanced Algorithms for Treatment Management Applications (AATMA) is the device name listed in this FDA 510(k) record. The listed applicant is Elekta Solutions AB. It received FDA 510(k) clearance on 2021-10-25 under 510(k) number K212218. The device is classified under product code QKB. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Advanced Algorithms for Treatment Management Applications (AATMA)?

Advanced Algorithms for Treatment Management Applications (AATMA) is a medical device that received FDA 510(k) clearance on 2021-10-25. The listed applicant is Elekta Solutions AB. The 510(k) number is K212218.

When did Advanced Algorithms for Treatment Management Applications (AATMA) receive FDA 510(k) clearance?

Advanced Algorithms for Treatment Management Applications (AATMA) received FDA 510(k) clearance on 2021-10-25, under 510(k) number K212218.

Who is the listed applicant for Advanced Algorithms for Treatment Management Applications (AATMA)?

The FDA 510(k) record lists Elekta Solutions AB as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Advanced Algorithms for Treatment Management Applications (AATMA)?

The FDA product code for Advanced Algorithms for Treatment Management Applications (AATMA) is QKB.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07488429Impact of rTMS Combined With Neurorehabilitation on Lower Extremity Motor Function and Spasticity in Children With Spastic Diplegic Cerebral PalsyRECRUITINGNCT07496346Integration of a Robotic Platform for Clinical Monitoring of Patients With Severe Acquired Brain Injury in High-Intensity Care UnitsNOT_YET_RECRUITINGNCT07773480Formative Evaluation of a Mobile Application Facilitated Self-directed Rehabilitation Programme for Knee OsteoarthritisNOT_YET_RECRUITING

Other records listing Elekta Solutions AB as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261932Leksell® Vantage Stereotactic SystemK252002Monaco RTP System (6.3)K252188EMLA (Elekta Evo); EMLA (VersaHD); EMLA (Elekta Harmony Pro); EMLA (Elekta Infintiy); EMLA (Elekta Harmony); EMLA (Elekta Synergy)K251363ProKnow DSK250391Leksell Gamma Knife® (Elekta Esprit); Leksell Gamma Knife® (Icon™); Leksell Gamma Knife® (Perfexion™)K232854Leksell GammaPlan (LGP)

View all 15 devices →

Related Devices (Code: QKB)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262452AutoContour (RADAC V6)Radformation, Inc.K261306AI Contouring (VA10A)Varian Medical SystemsK260528OncoStudioOncosoft. Inc.,K252548AI-Rad Companion Organs RTSiemens Healthcare GmbHK252190DeepBT Detector-PlusAitewan Biomedical Technology, Inc.K253270Contour ProtégéAI+Mim Software, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑